SACCHETTI, Emilio
SACCHETTI, Emilio
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study
2006-01-01 Gennarelli, Massimo; Bocchio Chiavetto, L; Valsecchi, Paolo; Scassellati, C; Pasqualetti, P; Bonvicini, C; Corsini, P; Rossi, G; Cesana, Bruno Mario; Barlati, Sergio; Sacchetti, Emilio
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study
2007-01-01 Sacchetti, Emilio; Bocchio-Chiavetto, Luisella; Valsecchi, Paolo; Scassellati, Catia; Pasqualetti, Patrizio; Bonvicini, Cristian; Corsini, Paola; Rossi, Giuseppe; Cesana, Bruno Mario; Barlati, Sergio; Gennarelli, Massimo
A genome-wide pharmacogenomic study of patients with schizophrenia suggests that GRM7 mediates the effects of risperidone on positive symptoms
2013-01-01 Magri, Chiara; Minelli, Alessandra; Traversa, Michele; Valsecchi, Paolo; Scassellati, C.; Sacchetti, Emilio; Gennarelli, Massimo
A multimodal imaging study of never-medicated adults with schizophrenia
2011-01-01 Filippi, M.; Canu, E.; Agosta, F.; Valsecchi, Paolo; Pagani, E.; Comi, G.; Gasparotti, Roberto; Sacchetti, Emilio
A randomized double-blind comparison of ziprasidone vs. clozapine for cognition in patients with schizophrenia selected for resistance or intolerance to previous treatment.
2008-01-01 Harvey, Pd; Sacchetti, Emilio; Galluzzo, A; Romeo, F; Gorini, B; Bilder, Rm; Loebel, Ad; Epub, Feb
A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: The QUERISOLA trial.
2008-01-01 Sacchetti, Emilio; Valsecchi, Paolo; Parrinello, Giovanni; FOR THE QUERISOLA, Group
A STUDY OF EFFECTIVENESS OF STRUCTURED GROUP PSYCHOEDUCATION FOR BIPOLAR PATIENTS. A CONTROLLED TRIAL IN ITALY
2011-01-01 Candini, V.; Buizza, Chiara; de Girolamo, G.; Ferrari, C.; Caldera, M. T.; Nobili, G.; Piolii, R.; Sacchetti, Emilio; Saviotti, F. M.; Seggioli, G.; Zanini, A.
Additional Evidence for White Matter Damage in Never-Medicated Adults with Schizophrenia and Schizophreniform Disorder
2012-01-01 Canu, E.; Gasparotti, Roberto; Agosta, F.; Valsecchi, Paolo; Pagani, E.; Comi, G.; Sacchetti, Emilio; Filippi, M.
Adherence to antipsychotics in schizophrenia.
2014-01-01 Sacchetti, Emilio; Vita, Antonio; Siracusano, A; Fleishhacker, Ww
Adult ADHD: Prevalence and Clinical Correlates in a Sample of Italian Psychiatric Outpatients
2018-01-01 Valsecchi, Paolo; Nibbio, Gabriele; Rosa, Jennifer; Tamussi, Elena; Turrina, Cesare; Sacchetti, Emilio; Vita, Antonio
Alpha reactivity in schizophrenia and in schizophrenic spectrum disorders: demographic, clinical and hemispheric assessment.
1989-01-01 Colombo, C; Gambini, O; Macciardi, F; Bellodi, L; Sacchetti, Emilio; Vita, Antonio; Cattaneo, R; Scarone, S.
Analysis of Copy Number Variations in Schizophrenia Italian Patients
2009-01-01 Traversa, Michele; Magri, Chiara; Valsecchi, Paolo; Gardella, Rita; Gennarelli, Massimo; Sacchetti, Emilio; Barlati, Sergio
Analysis of DTI brain data and implementation in a novel software (DTILAB)
2007-01-01 Carletti, Francesco; Grazioli, Riccardo; Signoroni, Alberto; L., Mascaro; Sacchetti, Emilio; Gasparotti, Roberto
Analysis of the (TA) repeat polymorphism of the UGT1A1 (UDP-Glucuronosyltransferase) gene in schizophrenia
2002-01-01 Gardella, Rita; Barlati, Sergio; BREDA KLOBUS, Andrea; Iatropoulos, Paraskevas; Bonomi, S; Mosca, A; Sacchetti, Emilio; Barlati, S.
Anticonvulsants in psychiatric disorders: focus on carbamazepine.
1990-01-01 Sacchetti, Emilio; Terzi, A.; Vita, Antonio
Antipsychotics, antidepressants, anticonvulsants, and placebo on symptom dimensions of borderline personality disorder: a meta-analysis of randomized controlled and open-label trials
2011-01-01 Vita, Antonio; DE PERI, Luca Mario; Sacchetti, Emilio
Are SSRI antidepressants a clinically homogeneous class of compounds?
1994-01-01 Sacchetti, Emilio; Conte, G; Guarneri, L.
Aripiprazole in the treatment of schizophrenia: a consensus report produced by schizophrenia experts in Italy.
2007-01-01 Cassano, Gb; Fagiolini, A; Lattanzi, L; Monteleone, P; Niolu, C; Sacchetti, Emilio; Siracusano, A; Vita, Antonio
Association study and mutational screening of SYNGR1 as a candidate susceptibility gene for schizophrenia
2009-01-01 Iatropoulos, P; Gardella, Rita; Valsecchi, Paolo; Magri, Chiara; Ratti, C; Podavini, D; Rossi, G; Gennarelli, Massimo; Sacchetti, Emilio; Barlati, Sergio
Association study between HTR2A rs6313 polymorphism and early response to risperidone and olanzapine in schizophrenia patients
2020-01-01 Maffioletti, E.; Valsecchi, P.; Minelli, A.; Magri, C.; Bonvicini, C.; Barlati, S.; Sacchetti, E.; Vita, A.; Gennarelli, M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| -G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study | 1-gen-2006 | Gennarelli, Massimo; Bocchio Chiavetto, L; Valsecchi, Paolo; Scassellati, C; Pasqualetti, P; Bonvicini, C; Corsini, P; Rossi, G; Cesana, Bruno Mario; Barlati, Sergio; Sacchetti, Emilio | |
| -G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study | 1-gen-2007 | Sacchetti, Emilio; Bocchio-Chiavetto, Luisella; Valsecchi, Paolo; Scassellati, Catia; Pasqualetti, Patrizio; Bonvicini, Cristian; Corsini, Paola; Rossi, Giuseppe; Cesana, Bruno Mario; Barlati, Sergio; Gennarelli, Massimo | |
| A genome-wide pharmacogenomic study of patients with schizophrenia suggests that GRM7 mediates the effects of risperidone on positive symptoms | 1-gen-2013 | Magri, Chiara; Minelli, Alessandra; Traversa, Michele; Valsecchi, Paolo; Scassellati, C.; Sacchetti, Emilio; Gennarelli, Massimo | |
| A multimodal imaging study of never-medicated adults with schizophrenia | 1-gen-2011 | Filippi, M.; Canu, E.; Agosta, F.; Valsecchi, Paolo; Pagani, E.; Comi, G.; Gasparotti, Roberto; Sacchetti, Emilio | |
| A randomized double-blind comparison of ziprasidone vs. clozapine for cognition in patients with schizophrenia selected for resistance or intolerance to previous treatment. | 1-gen-2008 | Harvey, Pd; Sacchetti, Emilio; Galluzzo, A; Romeo, F; Gorini, B; Bilder, Rm; Loebel, Ad; Epub, Feb | |
| A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: The QUERISOLA trial. | 1-gen-2008 | Sacchetti, Emilio; Valsecchi, Paolo; Parrinello, Giovanni; FOR THE QUERISOLA, Group | |
| A STUDY OF EFFECTIVENESS OF STRUCTURED GROUP PSYCHOEDUCATION FOR BIPOLAR PATIENTS. A CONTROLLED TRIAL IN ITALY | 1-gen-2011 | Candini, V.; Buizza, Chiara; de Girolamo, G.; Ferrari, C.; Caldera, M. T.; Nobili, G.; Piolii, R.; Sacchetti, Emilio; Saviotti, F. M.; Seggioli, G.; Zanini, A. | |
| Additional Evidence for White Matter Damage in Never-Medicated Adults with Schizophrenia and Schizophreniform Disorder | 1-gen-2012 | Canu, E.; Gasparotti, Roberto; Agosta, F.; Valsecchi, Paolo; Pagani, E.; Comi, G.; Sacchetti, Emilio; Filippi, M. | |
| Adherence to antipsychotics in schizophrenia. | 1-gen-2014 | Sacchetti, Emilio; Vita, Antonio; Siracusano, A; Fleishhacker, Ww | |
| Adult ADHD: Prevalence and Clinical Correlates in a Sample of Italian Psychiatric Outpatients | 1-gen-2018 | Valsecchi, Paolo; Nibbio, Gabriele; Rosa, Jennifer; Tamussi, Elena; Turrina, Cesare; Sacchetti, Emilio; Vita, Antonio | |
| Alpha reactivity in schizophrenia and in schizophrenic spectrum disorders: demographic, clinical and hemispheric assessment. | 1-gen-1989 | Colombo, C; Gambini, O; Macciardi, F; Bellodi, L; Sacchetti, Emilio; Vita, Antonio; Cattaneo, R; Scarone, S. | |
| Analysis of Copy Number Variations in Schizophrenia Italian Patients | 1-gen-2009 | Traversa, Michele; Magri, Chiara; Valsecchi, Paolo; Gardella, Rita; Gennarelli, Massimo; Sacchetti, Emilio; Barlati, Sergio | |
| Analysis of DTI brain data and implementation in a novel software (DTILAB) | 1-gen-2007 | Carletti, Francesco; Grazioli, Riccardo; Signoroni, Alberto; L., Mascaro; Sacchetti, Emilio; Gasparotti, Roberto | |
| Analysis of the (TA) repeat polymorphism of the UGT1A1 (UDP-Glucuronosyltransferase) gene in schizophrenia | 1-gen-2002 | Gardella, Rita; Barlati, Sergio; BREDA KLOBUS, Andrea; Iatropoulos, Paraskevas; Bonomi, S; Mosca, A; Sacchetti, Emilio; Barlati, S. | |
| Anticonvulsants in psychiatric disorders: focus on carbamazepine. | 1-gen-1990 | Sacchetti, Emilio; Terzi, A.; Vita, Antonio | |
| Antipsychotics, antidepressants, anticonvulsants, and placebo on symptom dimensions of borderline personality disorder: a meta-analysis of randomized controlled and open-label trials | 1-gen-2011 | Vita, Antonio; DE PERI, Luca Mario; Sacchetti, Emilio | |
| Are SSRI antidepressants a clinically homogeneous class of compounds? | 1-gen-1994 | Sacchetti, Emilio; Conte, G; Guarneri, L. | |
| Aripiprazole in the treatment of schizophrenia: a consensus report produced by schizophrenia experts in Italy. | 1-gen-2007 | Cassano, Gb; Fagiolini, A; Lattanzi, L; Monteleone, P; Niolu, C; Sacchetti, Emilio; Siracusano, A; Vita, Antonio | |
| Association study and mutational screening of SYNGR1 as a candidate susceptibility gene for schizophrenia | 1-gen-2009 | Iatropoulos, P; Gardella, Rita; Valsecchi, Paolo; Magri, Chiara; Ratti, C; Podavini, D; Rossi, G; Gennarelli, Massimo; Sacchetti, Emilio; Barlati, Sergio | |
| Association study between HTR2A rs6313 polymorphism and early response to risperidone and olanzapine in schizophrenia patients | 1-gen-2020 | Maffioletti, E.; Valsecchi, P.; Minelli, A.; Magri, C.; Bonvicini, C.; Barlati, S.; Sacchetti, E.; Vita, A.; Gennarelli, M. |